4. Evasyst Convertible Notes

In 2022, prior to the completion of the Merger on April 22, 2022, the Company issued additional convertible notes with the same terms as existing convertible notes as follows:

Consulting expense	$	613,250
Accrued wages		17,917
	$	631,167

The convertible notes issued for consulting were to satisfy payables due for expenses incurred by Leawood VC Fund LP and Fairmont Capital, Inc., entities associated with major shareholders of the Company. The related consulting services were associated with the Merger on April 22, 2022. The fair value of the consulting expenses was based upon the number of Company shares the debtholder ultimately received upon conversion of the notes multiplied by the trading price of the shares on the date of the note.

At merger date, April 22, 2022 and December 31, 2021, the balance of convertible debt was $3,346,510 and $2,715,343, respectively. Related accrued interest was nil and $210,013, respectively.

During the three months ended June 30, 2022, all convertible notes and accrued interest were converted into 584,984 shares of common stock in connection with the completion of the Merger.

At the Merger date, April 22, 2022 and December 31, 2021, convertible notes and accrued interest payable were due to the following related parties as follows:

			Convertible Debt				Accrued Interest Payable
			April 22, 2022		December 31, 2022		April 22, 2022		December 31, 2022
Mark Ollila	CEO, Director	$	11,905	$	11,905	$	833	$	596
Company associated with Michael Gibbons	Director		550,000		550,000		55,681		44,756
Leawood VC Fund 1 LP	> 5% shareholder		250,000		250,000		26,911		21,945
Trust associated with Stephen Petilli	Director		100,000		100,000		9,619		7,633
		$	911,905	$	911,905	$	93,044	$	74,930